<bill session="112" type="h" number="3827" updated="2022-03-01T05:34:22Z">
  <state datetime="2012-01-25">REFERRED</state>
  <status>
    <introduced datetime="2012-01-25"/>
  </status>
  <introduced datetime="2012-01-25"/>
  <titles>
    <title type="display">To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding.</title>
    <title type="official" as="introduced">To repeal the Patient-Centered Outcomes Research program and comparative effectiveness research funding.</title>
  </titles>
  <sponsor bioguide_id="G000558"/>
  <cosponsors>
    <cosponsor bioguide_id="B000213" joined="2012-01-25"/>
    <cosponsor bioguide_id="B001271" joined="2012-01-25"/>
    <cosponsor bioguide_id="B001243" joined="2012-01-25"/>
    <cosponsor bioguide_id="K000369" joined="2012-02-06"/>
    <cosponsor bioguide_id="M001159" joined="2012-01-25"/>
    <cosponsor bioguide_id="R000572" joined="2012-01-25"/>
    <cosponsor bioguide_id="W000413" joined="2012-02-27"/>
  </cosponsors>
  <actions>
    <action datetime="2012-01-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2012-01-25" state="REFERRED">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committees on Appropriations, the Budget, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2012-01-25">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committees on Appropriations, the Budget, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2012-01-25">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committees on Appropriations, the Budget, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2012-01-25">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committees on Appropriations, the Budget, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2012-02-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSBU" name="House Budget" subcommittee="" activity="Referral"/>
    <committee code="HSAP" name="House Appropriations" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Appropriations"/>
    <term name="Budget deficits and national debt"/>
    <term name="Department of Health and Human Services"/>
    <term name="Executive agency funding and structure"/>
    <term name="Health care quality"/>
    <term name="Health programs administration and funding"/>
    <term name="Medical research"/>
    <term name="Research administration and funding"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2012-05-08T21:16:35Z" status="Introduced in House">Repeals provisions of the Patient Protection and Affordable Care Act and the Internal Revenue Code, and rescinds all unobligated funds, that provide for the establishment and funding of the Patient-Centered Outcomes Research Institute to identify priorities for, and establish, update, and carry out, a national comparative outcomes research project agenda, as well as that provide for the dissemination of the research findings published by the Institute and other government-funded research that are relevant to comparative clinical effectiveness research.

Rescinds all remaining unobligated balances available to the Agency for Healthcare Research and Quality for purposes of comparative effectiveness research.

Requires the total amount rescinded by this Act to be deposited in the Treasury to pay down the national debt.</summary>
</bill>
